Though generic drugs represent more than 90% of dispensed prescriptions, generic drug manufacturers continue to face pressure from drug distributors, pharmacy benefit managers, and competitors. But ...
As Amarin faces generic competition in the U.S. for its heart drug Vascepa, it is changing up its game plan. The strategy? Reduce its boots on the ground and lean into digital marketing. Amarin plans ...
As the cost of branded drugs is increasing faster than ever, challenging the purchasing power of patients, the demand for generic medicines is on the rise. Generic medicines, the patent-expired ...
A persistent drug shortage crisis in the U.S. is associated with higher mortality rates, medication errors, delays in life-saving cancer treatment and other critical medical procedures, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results